Wells Fargo & Company X Biotech Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in X Biotech Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 8,129 shares of XBIT stock, worth $50,887. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,129
Previous 155
5144.52%
Holding current value
$50,887
Previous $1,000
4000.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding XBIT
# of Institutions
47Shares Held
4.67MCall Options Held
5.8KPut Options Held
4.6K-
Black Rock Inc. New York, NY1.13MShares$7.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$6.49 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA430KShares$2.69 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny362KShares$2.26 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL248KShares$1.55 Million0.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $191M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...